A C Spyropoulos. Show Affiliations »
Abstract
Mesh: See more » Fibrinolytic Agents/adverse effectsHeparin, Low-Molecular-Weight/therapeutic useHumansPerioperative CarePostoperative Hemorrhage/chemically inducedRisk FactorsThromboembolism/prevention & controlVitamin K/adverse effectsVitamin K/antagonists & inhibitorsVitamin K/therapeutic use
Substances: See more » Fibrinolytic AgentsHeparin, Low-Molecular-WeightVitamin K
Year: 2007 PMID: 17634821 DOI: 10.1007/s11739-007-0043-9
Source DB: PubMed Journal: Intern Emerg Med ISSN: 1828-0447 Impact factor: 3.397